¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"negative regulation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gram-negative bacterium
    ±×¶÷À½¼º±Õ
  • lower body negative pressure
    ÇÏüÀ½¾Ð
  • negative
    1. ¿ª-, ºÎÁ¤Àû- 2. À½¼º-
  • negative affect
    ºÎÁ¤Á¤µ¿
  • negative afterimage
    À½¼ºÀÜ»ó
  • negative assumption
    ºÎÁ¤Àû°¡Á¤
  • negative base excess
    ¿ª¿°±â°úÀ×
  • negative catalysis
    ¿ªÃ˸ÅÀÛ¿ë
  • negative catalyst
    ¿ªÃ˸ÅÁ¦
  • negative charge
    À½ÀüÇÏ
  • negative convergence
    À½¼º´«¸ðÀ½
  • negative declination
    ³»È¸¼±
  • negative dromotropism
    °¨¼ÒÀüµµ¿µÇ⼺, º¯Á¶°¨¼Ò
  • negative feedback
    À½¼ºµÇ¸ÔÀÓ
  • negative feedback mechanism
    À½¼ºµÇ¸ÔÀÓ±âÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • negative affect
    ºÎÁ¤Á¤µ¿
  • negative afterimage
    À½¼ºÀÜ»ó
  • negative assumption
    ºÎÁ¤Àû°¡Á¤
  • Gram-negative bacterium
    ±×¶÷À½¼º±Õ
  • negative nitrogen balance
    À½¼ºÁú¼ÒÆòÇü
  • negative pressure breathing
    À½¾ÐÈ£Èí
  • negative catalysis
    ¿ªÃ˸ÅÀÛ¿ë
  • negative catalyst
    ¿ªÃ˸ÅÁ¦
  • negative charge
    À½ÀüÇÏ
  • negative convergence
    À½¼º´«¸ðÀ½
  • negative declination
    ³»È¸¼±
  • negative dromotropism
    °¨¼ÒÀüµµ¿µÇ⼺, º¯Á¶°¨¼Ò, ¹æ½ÇÀüµµ¾ïÁ¦
  • egg negative conversion rate
    Ãæ¶õÀ½ÀüÀ²
  • negative electricity
    À½Àü±â
  • negative electrode
    À½±Ø
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Rh negative
    Rh À½¼º
  • SANS, Scale for the Assessment of Negative Symptoms
    À½¼ºÁõ»óÆò°¡Ã´µµ
  • aerobic gram-negative rod
    È£±â¼º ±×¶÷À½¼º°£±Õ
  • gram negative sepsis
    ±×·¥À½¼ºÆÐÇ÷Áõ.
  • gram negative shock
    ±×·¥À½¼º¼ï.
  • gram-negative bacteremia
    ±×·¥ À½¼º ±ÕÇ÷Áõ
  • gram-negative infection,anaerobic
    ±×·¥ À½¼º °¨¿°,Çø±â¼º
  • gram-negative rods
    ±×·¥ À½¼º °£±Õ
  • hallucination, negative
    À½¼ºÈ¯°¢(ëäàõü³ÊÆ)
  • positive negative pressure respiration
    ¾çÀ½¾ÐÈ£Èí(¹ý)(åÕëääâû¼ýåÛö), ¾ç À½¾Ðȯ±â(¹ý)(¡­üµÑ¨Ûö).
  • positive negative pressure ventilation
    ¾çÀ½¾ÐÈ£Èí(¹ý), ¾çÀ½¾Ðȯ±â(¹ý).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • regulation
    ±ÔÁ¤
  • regulation of acid base equilibrium
    »ê-¿°±âÆòÇüÁ¶Àý(ß«ç¤ÐñøÁû¬ðàï½).
  • regulation of body temperature
    ü¿ÂÁ¶Àý(ô÷è®ðàï½).
  • regulation of gastric secretion
    À§»êºÐºñÁ¶Àý(êÖß«ÝÂù²ðàï½).
  • respiration regulation
    È£ÈíÁ¶Àý.
  • self regulation
    ÀÚ°¡Á¶Àý(í»Ê«ðàï½).
  • temperature regulation
    ü¿ÂÁ¶Àý(ô÷è® ðàï½).
  • toxic chemical regulation
    µ¶¼ºÈ­Çй°Áú±ÔÁ¤
  • aerobic gram-negative rod
    È£±â¼º ±×¶÷À½¼º°£±Õ
  • bacteremia,gram-negative
    ±×¶÷ À½¼º
  • bacterium, Gram-negative
    ±×¶÷À½¼º¼¼±Õ
  • coagulase-negative staphylococcus
    ÄھƱֶóÁ¦ À½¼º(~ ëäàõ) Æ÷µµ±¸±Õ(øÑԬϹж)
  • enteric Gram negative bacillus
    Àå³»±×¶÷À½¼º°£±Õ(¡­ëäàõ ж).
  • false negative
    °¡À½¼º.
  • false negative reaction
    °¡À½¼º ¹ÝÀÀ.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • negative phase
    °¨¼Ò±â(Êõá´Ñ¢)
  • negative polarity
    À½±Ø¼º(ëäпàü)
  • negative supercoil
    À½(ëä) ¼öÆÛÄÚÀÏ
  • negative superhelix
    À½(ëä) ¼öÆÛ³ª¼±
  • transport-negative mutant
    ¼ö¼Û°áÇÔ º¯ÀÌÁÖ(âÃáêÌÀùèܨì¶ñ»)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PNP pancreatic polypeptide; para-nitrophenol; peak negative pressure; pediatric nurse practitioner; peri...
CNPV Continuous Negative Pressure Ventilation
GNB Gram Negative(-) Bacilli
GNBP Gram Negative(-) Bacillary Pneumonias
INPV Intermittent Negative Pressure Ventilation; °£ÇæÀû À½¾Ðȯ±â ¿ä¹ý
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DN Double negative
ER- Estrogen receptor negative
FN False negative
FNR False negative rate
FHN Family History Negative
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • false-negative diagnosis
    À§À½¼º Áø´Ü
  • negative balance
    À½¼º ±ÕÇü
  • negative biofeedback
    À½¼º ¹ÙÀÌ¿À Çǵå¹é
  • negative charge
    À½ ÇÏÀü, À½ ÀüÇÏ
  • negative cognitive factor
    ºÎÁ¤ÀûÀÎ ÀÎ½Ä ¿äÀεé
  • negative diascopy
    À½¼º ¾Ð½Ã¹ý
  • negative drug history
    À½¼º Åõ¾à º´·Â
  • negative electrode
    À½±Ø
  • negative entropy
    À½ ¿£Æ®·ÎÇÇ
  • negative feedback inhibition
    À½¼º µÇ¸ÔÀ̱⠾ïÁ¦
  • negative hallucination
    À½¼º ȯ°¢
  • negative impression technique
    À½ Àλó ¼ú½Ä
    ¿©·¯ °¡Áö Àλó¹ý Áß¿¡¼­ Á¶Á÷ÀÌ Á¤ÀûÀÎ »óÅ¿¡¼­ ¾ò¾îÁö´Â Àλó¹ýÀ» ¶æÇÏ¸ç ¶§·Î´Â mucostatic im
  • negative ion
    À½ ÀÌ¿Â
  • negative phosphorus balance
    À½ ÀÎ»ê ±ÕÇü
  • negative predictive value
    À½¼º ¿¹»óÄ¡
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
down-regulation <physiology> Development of a refractory or tolerant state consequent upon repeated administration of a pharmacologically or physiologically active substance.
It is the process that decreases ligand and receptor interactions or reduces the responsiveness of a cell to a stimulus following first exposure.
This is often accompanied by an initial decrease in affinity of receptors for the agent and a subsequent reduction in the number of available receptors expressed on the surface which can result from internalisation of the ligand:receptor complex or from decreased expression of the receptor.
Classically the concept referred to hormone receptors but contemporary usage includes other cell surface receptors.
(03 Jul 1999)
target regulation <physiology> General term for an interaction between neurons and their targets by which target derived signals influence the differentiation of the innervating neurons.
(18 Nov 1997)
enzyme regulation <biochemistry> Control of the rate of a reaction catalyzed by an enzyme by some effector (e.g., inhibitors or activators) or by alteration of some condition (e.g., pH or ionic strength).
(05 Mar 2000)
facility regulation and control Formal voluntary or governmental procedures and standards required of hospitals and health or other facilities to improve operating efficiency, and for the protection of the consumer.
(12 Dec 1998)
feedback regulation <physiology> Control mechanism that uses the consequences of a process to regulate the rate at which the process occurs: if, for example: the products of a reaction inhibit the reaction from proceeding (or slow down the rate of the reaction), then there is negative feedback, something that is very common in metabolic pathways.
Positive feedback is liable to lead to exponential increase and may be explosively dangerous in some cases.
Other examples are the action of voltage dependent sodium channels in generating action potentials and the activation of blood clotting factors V and VIII by thrombin. Without damping, feedback can lead to resonance (hunting) and oscillation in the system.
(18 Nov 1997)
up-regulation Opposite of down-regulation.
(05 Mar 2000)
up-regulation (physiology) Process that increases ligand/receptor interactions due to an increase in the number of available receptors.
(12 Dec 1998)
bone scan: falsely negative metastases <radiology> Anaplastic tumours, reticulum cell sarcoma, renal cell carcinoma, thyroid carcinoma, histiocytosis, neuroblastoma, multiple myeloma (positive scan usually due to recent or impending fracture)
(12 Dec 1998)
ventilators, negative-pressure Body ventilators that assist ventilation by applying intermittent subatmospheric pressure around the thorax, abdomen, or airway and periodically expand the chest wall and inflate the lungs. They are relatively simple to operate and do not require tracheostomy. These devices include the tank ventilators ("iron lung"), portalung, pneumowrap, and chest cuirass ("tortoise shell").
(12 Dec 1998)
gram-negative <microbiology> A common class of bacteria normally found in the gastrointestinal tract that can be responsible for disease in man (sepsis).
Bacteria are considered to be gram-negative because of their characteristic staining properties under the microscope, where they either do not stain or are decolourised by alcohol during Gram's method of staining.
This is a primary characteristic of bacteria that have a cell wall composed of a thin layer of peptidoglycan covered by an outer membrane of lipoprotein and lipopolysaccharide containing endotoxin.
The gram staining characteristics of bacteria have resulted in an important classification system for the identification of bacteria.
See: gram-positive
(06 Oct 1997)
gram-negative aerobic bacteria <microbiology> A large group of aerobic bacteria which show up as pink (negative) when treated by the gram-staining method.
(12 Dec 1998)
gram-negative aerobic rods and cocci <microbiology> A group of gram-negative bacteria consisting of rod- and coccus-shaped cells.
They are both aerobic (able to grow under an air atmosphere) and microaerophilic (grow better in low concentrations of oxygen) under nitrogen-fixing conditions but, when supplied with a source of fixed nitrogen, they grow as aerobes.
(12 Dec 1998)
gram-negative anaerobic bacteria <microbiology> A large group of anaerobic bacteria which show up as pink (negative) when treated by the gram-staining method.
(12 Dec 1998)
gram-negative anaerobic cocci <microbiology> A group of anaerobic coccoid bacteria that show up as pink (negative) when treated by the gram-staining method.
(12 Dec 1998)
gram-negative anaerobic straight, curved, and helical rods <microbiology> A group of anaerobic, rod-shaped bacteria that show up as pink (negative) when treated by the gram-staining method.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • negative evidence
    (¹ý)¼Ò±ØÀû Áõ°Å;¹ÝÁõ
  • negative feedback
    À½ µÇ¸ÔÀÓ;À½ Çǵå¹é
  • negative growth
    (°æÁ¦ÀÇ)¸¶À̳ʽº ¼ºÀå
  • negative income tax
    ¿ª ¼Òµæ¼¼(Àú¼ÒµæÀÚ¿¡°Ô Á¤ºÎ°¡ Áö±ÞÇÏ´Â º¸Á¶±Ý
  • negative interest
    ¿ª±Ý¸®,¸¶À̳ʽº ±Ý¸®
  • negative list
    ³×°ÅƼºê,¸®½ºÆ®(GATT¿¡ º¸°íÇÏ´Â ¼öÀÔÁ¦ÇÑ Ç°¸ñ
  • negative option
    ÁÖ¹®ÇÏÁö ¾ÊÀº »óǰÀÌ ¿ì¼ÛµÅ ¿ÔÀ»¶§ÀÇ ¼öÃëÀÎÀÇ ¼±ÅñÇ
  • negative pole
    (ÀÚ¼®ÀÇ)³²±Ø;(Àü)À½±Ø
  • negative quantity
    À½¼ö;ÀÍ»ì;¹«
  • negative sign
    (¼ö)¸¶À̳ʽº ±âÈ£;°¨È£
  • negative transfer
    ¼Ò±ØÀû ÀüÀÌ(ÇнÀ °úÁ¤¿¡¼­ ¼±Çà ÇнÀÀÌ ÈÄÀÇ ÇнÀÀ» ¹æÇØ ¾ïÁ¦
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á